ATE265218T1 - Chlorella zubereitungen mit immunmodulatorischen eigenschaften - Google Patents

Chlorella zubereitungen mit immunmodulatorischen eigenschaften

Info

Publication number: ATE265218T1
Authority: AT; Austria
Prior art keywords: extracts; polysaccharide; chlorella; cleavage; linkages
Prior art date: 2000-08-10

Application number

AT01966835T

Other languages

English (en)

Inventor

Jaroslav A Kralovec

Original Assignee

Ocean Nutrition Canada Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-08-09

Publication date

2004-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22838933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE265218(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-08-09 Application filed by Ocean Nutrition Canada Ltd filed Critical Ocean Nutrition Canada Ltd

2004-05-15 Application granted granted Critical

2004-05-15 Publication of ATE265218T1 publication Critical patent/ATE265218T1/de

Links

241000195649 Chlorella <Chlorellales> Species 0.000 title abstract 4
230000002519 immonomodulatory effect Effects 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title 1
239000000284 extract Substances 0.000 abstract 4
150000004676 glycans Chemical class 0.000 abstract 4
229920001282 polysaccharide Polymers 0.000 abstract 4
239000005017 polysaccharide Substances 0.000 abstract 4
238000003776 cleavage reaction Methods 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
230000007017 scission Effects 0.000 abstract 2
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 abstract 1
239000004382 Amylase Substances 0.000 abstract 1
102000013142 Amylases Human genes 0.000 abstract 1
108010065511 Amylases Proteins 0.000 abstract 1
108010059892 Cellulase Proteins 0.000 abstract 1
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 1
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
108090001005 Interleukin-6 Proteins 0.000 abstract 1
SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 abstract 1
PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 abstract 1
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 abstract 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
102000005348 Neuraminidase Human genes 0.000 abstract 1
108010006232 Neuraminidase Proteins 0.000 abstract 1
108091005804 Peptidases Proteins 0.000 abstract 1
102000035195 Peptidases Human genes 0.000 abstract 1
108010059712 Pronase Proteins 0.000 abstract 1
239000004365 Protease Substances 0.000 abstract 1
108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
235000019418 amylase Nutrition 0.000 abstract 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 1
229940106157 cellulase Drugs 0.000 abstract 1
229930182830 galactose Natural products 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
229920002477 rna polymer Polymers 0.000 abstract 1
210000004988 splenocyte Anatomy 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
239000013589 supplement Substances 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/946—Microorganisms using algae

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Natural Medicines & Medicinal Plants (AREA)
Biotechnology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Oncology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Microbiology (AREA)
Alternative & Traditional Medicine (AREA)
Botany (AREA)
Medical Informatics (AREA)
Mycology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Seeds, Soups, And Other Foods (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Compounds Of Unknown Constitution (AREA)

AT01966835T 2000-08-10 2001-08-09 Chlorella zubereitungen mit immunmodulatorischen eigenschaften ATE265218T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22401400P	2000-08-10	2000-08-10
PCT/CA2001/001138 WO2002011746A2 (en)	2000-08-10	2001-08-09	Chlorella preparations exhibiting immunomodulating properties

Publications (1)

Publication Number	Publication Date
ATE265218T1 true ATE265218T1 (de)	2004-05-15

Family

ID=22838933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01966835T ATE265218T1 (de)	2000-08-10	2001-08-09	Chlorella zubereitungen mit immunmodulatorischen eigenschaften

Country Status (9)

Country	Link
US (3)	US6551596B2 (de)
EP (1)	EP1307213B1 (de)
JP (1)	JP2004505925A (de)
AT (1)	ATE265218T1 (de)
AU (2)	AU8738201A (de)
CA (1)	CA2354832C (de)
DE (1)	DE60103066T2 (de)
ES (1)	ES2220800T3 (de)
WO (1)	WO2002011746A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002015721A2 (de) *	2000-08-22	2002-02-28	Arimedes Biotechnology Gmbh	Zusammensetzungen zur nahrungsmittel- und tierfutterergänzung
WO2004083401A2 (en) *	2003-03-18	2004-09-30	Timothy Nicholas Ray	Broken cell wall chlorella and process for preparation thereof
CN1210038C (zh) *	2003-03-27	2005-07-13	中国人民解放军第三军医大学	N－乙酰氨基葡萄糖在制备用于治疗毒物和药物中毒致脏器损伤的药物中的应用
CN1297568C (zh) *	2003-08-08	2007-01-31	吉林威威药业股份有限公司	一种松果菊多糖、其制备方法及其在制备治疗抗病毒、抗菌及抗sars药物上的用途
US7807622B2 (en) *	2004-04-23	2010-10-05	Health Enhancement Products, Inc.	Composition and use of phyto-percolate for treatment of disease
US10166270B2 (en)	2004-04-23	2019-01-01	Zivo Bioscience, Inc.	Composition and method for affecting cytokines and NF-κB
CA2564466A1 (en) *	2004-04-23	2005-12-01	Health Enhancement Products, Inc.	Method of preparation and use of fibrinolytic enzymes in the treatment of disease
US7846452B2 (en) *	2004-07-30	2010-12-07	The University Of Mississippi	Potent immunostimulatory extracts from microalgae
AU2006320264A1 (en) *	2005-04-20	2007-06-07	Health Enhancement Products, Inc.	Composition and use of phyto-percolate for treatment of disease
US8586053B2 (en) *	2005-09-21	2013-11-19	Health Enhancement Products, Inc.	Composition and use of phyto-percolate for treatment of disease
US20090274736A1 (en) *	2006-01-19	2009-11-05	Solazyme Inc.	Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
US20070191303A1 (en) *	2006-01-19	2007-08-16	Solazyme, Inc.	Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions
US8298548B2 (en)	2007-07-18	2012-10-30	Solazyme, Inc.	Compositions for improving the health and appearance of skin
US8277849B2 (en) *	2006-01-19	2012-10-02	Solazyme, Inc.	Microalgae-derived compositions for improving the health and appearance of skin
US20070166266A1 (en) *	2006-01-19	2007-07-19	Solazyme, Inc.	Methods and compositions for improving the health and appearance of skin
KR100827422B1 (ko)	2006-05-19	2008-05-06	에프엔바이오(주)	클로렐라 추출물의 제조방법
US20080124318A1 (en) *	2006-11-28	2008-05-29	Jerold Lisson	Algae supplement and treatment method
US20080124286A1 (en) *	2006-11-28	2008-05-29	Lisson Jerold B	Algae supplement and treatment method
CL2008002020A1 (es)	2007-07-12	2008-11-14	Ocean Nutrition Canada Ltd	Metodo de modificacion de un aceite, que comprende hidrolizar gliceridos con una solucion de lipasa thermomyces lanuginosus, separar la fraccion de acido graso saturado de la fraccion de glicerido hidrolizado y esterificar los gliceridos hidrolizados en la presencia de candida antarctica lipasa b; y composicion de aceite.
US8343753B2 (en)	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
EP2211881A4 (de) *	2007-11-01	2012-01-04	Wake Forest University School Of Medicine	Zusammensetzungen und verfahren zur prävention und behandlung von krankheiten von säugetieren
CA2723484A1 (en) *	2008-05-06	2009-11-12	Ocean Nutrition Canada Limited	Compositions obtained from chlorella extract having immunomodulating properties
FR2931071B1 (fr) *	2008-05-14	2010-08-13	Roquette Freres	Confiserie aux algues pour la prevention des infections buccodentaires
US8927522B2 (en)	2008-10-14	2015-01-06	Solazyme, Inc.	Microalgal polysaccharide compositions
WO2010111710A1 (en) *	2009-03-27	2010-09-30	Solazyme, Inc.	Microalgal polysaccharide compositions
US8557249B2 (en)	2008-11-07	2013-10-15	Solazyme, Inc.	Cosmetic compositions comprising microalgal components
EP2501390A4 (de) *	2009-11-16	2014-07-02	Health Enhancement Products Inc	Zusammensetzungen und verfahren mit wirkung auf cytokine und nf-kb
CA2827401A1 (en)	2010-02-22	2011-08-25	Health Enhancement Products, Inc.	Agents and mechanisms for treating hypercholesterolemia
EP2574170A4 (de)	2010-05-10	2013-11-20	Ascend Biopharmaceuticals Pty Ltd	Immunstimulations- und impfstoffzusammensetzungen
AU2012200183B2 (en) *	2010-05-10	2012-09-20	Ascend Biopharmaceuticals Pty Ltd	Immunostimulatory and vaccine compositions
EP2497479A1 (de) *	2011-03-07	2012-09-12	IGV Institut für Getreideverarbeitung GmbH	Extrakte aus phototrophen Mikroorganismen als Adjuvans
WO2014074770A2 (en)	2012-11-09	2014-05-15	Heliae Development, Llc	Balanced mixotrophy methods
WO2014074772A1 (en)	2012-11-09	2014-05-15	Heliae Development, Llc	Mixotrophic, phototrophic, and heterotrophic combination methods and systems
EP2996672A4 (de)	2013-05-15	2016-11-02	Terravia Holdings Inc	Kosmetische zusammensetzungen mit mikroalgenöl
WO2014201372A1 (en)	2013-06-13	2014-12-18	Health Enhancement Products, Inc.	Compounds and methods for affecting cytokines
JP6144997B2 (ja) *	2013-08-27	2017-06-07	浩子伊藤	補体第３成分活性化剤
WO2015140467A1 (fr) *	2014-03-18	2015-09-24	Roquette Freres	Procédé de perméabilisation thermique d'une biomasse de microalgues
EP3034612A1 (de)	2014-12-16	2016-06-22	Greenaltech, S.L.	Chitin- und Chitosanherstellungsverfahren
PL3258948T3 (pl)	2015-02-16	2024-04-22	Zivo Bioscience, Inc.	Kompozycje przeciwzapalne i immunomodulujące zawierające klebsormidium i ich zastosowania
CN109414053A (zh)	2016-02-16	2019-03-01	齐沃生物科学股份有限公司	经由给予源自藻类的补充物的动物营养支持
RU2677340C2 (ru) *	2016-11-29	2019-01-16	Анна Леоновна Туманова	Способ оздоровления населения
JP2018203667A (ja) *	2017-06-06	2018-12-27	浩子伊藤	クロレラ・ピレノイドサの細胞壁破砕物から分離されるペプチドヘテロ多糖体を活性成分とする抗腫瘍剤
CN107142243B (zh) *	2017-06-29	2021-01-01	青岛麦迪赛斯医疗技术有限公司	一种增强人脐带间充质干细胞旁分泌能力的培养方法
CN107625783A (zh) *	2017-08-09	2018-01-26	天津科技大学	硫酸酯化小球藻、螺旋藻复合多糖在免疫调节领域的应用
EP3820512B1 (de) *	2018-07-02	2024-04-24	Ayuvis Research, Inc.	Immunmodulierende oligosaccharidderivate umfassende zusammensetzungen
MX2020014087A (es) *	2018-07-02	2021-04-12	Ayuvis Res Inc	Moléculas inmunomoduladoras pequeñas novedosas.
CN112457425B (zh) *	2020-12-09	2022-12-02	宁夏医科大学	一种具有抗肝癌细胞增殖活性的小球藻多糖的提纯方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3462412A (en) *	1966-04-20	1969-08-19	Tohoku Yakult Seizo Kk	Process of producing an active substance for stimulating the function of the reticulo-endothelial system
JPS5234944A (en)	1975-09-13	1977-03-17	Yoshiho Tanaka	Method of producing chlorella contained fatty food
JPS6044287B2 (ja)	1975-11-28	1985-10-02	株式会社ヤクルト本社	制癌剤の製造法
JPS5714533A (en)	1980-06-29	1982-01-25	Koutaku Hayashi	Preparation for immunochemical therapy, prevention of drug resistance and anticancer
JPS5815920A (ja) *	1981-07-23	1983-01-29	Kurorera Kogyo Kk	リンパ球増加剤
JPS5896025A (ja) *	1981-12-02	1983-06-07	Kitasato Inst:The	新規生理活性物質ｃｈ−１およびその製造法
JPS6178729A (ja)	1984-09-26	1986-04-22	Nisshin Oil Mills Ltd:The	免疫賦活化作用成分
JPS6196992A (ja)	1984-10-17	1986-05-15	Kurorera Kogyo Kk	粘質多糖体の製造法
JPS61197525A (ja) *	1985-02-27	1986-09-01	Nisshin Oil Mills Ltd:The	抗腫瘍活性をもつ免疫賦活化剤
JPS633764A (ja) *	1986-06-24	1988-01-08	Nisshin Oil Mills Ltd:The	種苗用飼料
CA1332650C (en)	1987-06-18	1994-10-18	Kunitaka Hirose	Polysaccharides and antiviral drugs containing the same as active ingredient
JPH0539894A (ja)	1991-07-31	1993-02-19	Toyota Motor Corp	シリンダヘツドカバーの取付構造
JPH0721003B2 (ja)	1993-03-01	1995-03-08	クロレラ工業株式会社	多糖体およびその製造方法
AU714310B2 (en) *	1995-05-12	1999-12-23	Japan Pharmaceutical Development Co., Ltd	Plant extract
JP2934658B2 (ja)	1995-12-25	1999-08-16	美穂田中	クロレラエキス粉末の製造法
US6027900A (en)	1996-04-12	2000-02-22	Carnegie Institution Of Washington	Methods and tools for transformation of eukaryotic algae
US6172220B1 (en) *	1997-01-21	2001-01-09	Board Of Regents Of University Of Nebraska	Isolated algal lipopolysaccharides and use of same to inhibit endotoxin-initiated sepsis
US5871952A (en)	1997-04-14	1999-02-16	Midwest Research Institute	Process for selection of Oxygen-tolerant algal mutants that produce H2
US6183968B1 (en) *	1998-03-27	2001-02-06	Incyte Pharmaceuticals, Inc.	Composition for the detection of genes encoding receptors and proteins associated with cell proliferation
CA2270106C (en)	1999-04-23	2006-03-14	Yousef Haj-Ahmad	Nucleic acid purification and process
MXPA03000220A (es)	2000-07-10	2003-10-15	Univ Mississippi	Inmunoestimulantes potentes de microalgas.

2001
- 2001-08-09 AT AT01966835T patent/ATE265218T1/de not_active IP Right Cessation
- 2001-08-09 ES ES01966835T patent/ES2220800T3/es not_active Expired - Lifetime
- 2001-08-09 JP JP2002517081A patent/JP2004505925A/ja active Pending
- 2001-08-09 CA CA002354832A patent/CA2354832C/en not_active Expired - Fee Related
- 2001-08-09 AU AU8738201A patent/AU8738201A/xx active Pending
- 2001-08-09 DE DE60103066T patent/DE60103066T2/de not_active Revoked
- 2001-08-09 EP EP01966835A patent/EP1307213B1/de not_active Revoked
- 2001-08-09 AU AU2001287382A patent/AU2001287382B8/en not_active Ceased
- 2001-08-09 WO PCT/CA2001/001138 patent/WO2002011746A2/en not_active Ceased
- 2001-08-10 US US09/925,953 patent/US6551596B2/en not_active Expired - Fee Related
2003
- 2003-02-19 US US10/367,795 patent/US6977076B2/en not_active Expired - Fee Related
- 2003-12-08 US US10/728,943 patent/US6974576B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2354832C (en)	2002-05-14
JP2004505925A (ja)	2004-02-26
EP1307213A2 (de)	2003-05-07
EP1307213B1 (de)	2004-04-28
US6974576B2 (en)	2005-12-13
US20020031524A1 (en)	2002-03-14
DE60103066D1 (de)	2004-06-03
US6977076B2 (en)	2005-12-20
DE60103066T2 (de)	2005-04-28
US20040081665A1 (en)	2004-04-29
AU2001287382B9 (en)	2006-10-26
AU8738201A (en)	2002-02-18
CA2354832A1 (en)	2001-10-29
WO2002011746A3 (en)	2002-09-06
US6551596B2 (en)	2003-04-22
US20030152587A1 (en)	2003-08-14
ES2220800T3 (es)	2004-12-16
WO2002011746A2 (en)	2002-02-14
AU2001287382B8 (en)	2006-10-26
AU2001287382B2 (en)	2006-08-17

Legal Events

Date	Code	Title	Description
2004-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE265218T1 (de)	2004-05-15	Chlorella zubereitungen mit immunmodulatorischen eigenschaften
Vo et al.	2015	The beneficial properties of marine polysaccharides in alleviation of allergic responses
Sarangi et al.	2006	Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans
Cassaro et al.	1977	Distribution of sulfated mucopolysaccharides in invertebrates.
Koch et al.	2015	Keeping track of the growing number of biological functions of chitin and its interaction partners in biomedical research
Bzducha-Wróbel et al.	2013	Chemical composition of the cell wall of probiotic and brewer’s yeast in response to cultivation medium with glycerol as a carbon source
Sanina	2019	Vaccine adjuvants derived from marine organisms
Wilson et al.	2015	Immune gene expression profile of Penaeus monodon in response to marine yeast glucan application and white spot syndrome virus challenge
AU2013257798B2 (en)	2017-11-16	Polysaccharides from Prasinococcales
Llauradó et al.	2015	In-vitro antimicrobial activity and complement/macrophage stimulating effects of a hot-water extract from mycelium of the oyster mushroom Pleurotus sp.
CN109517752B (zh)	2020-12-29	一种胞外多糖及其应用
Qiao et al.	2010	Immunostimulatory activity of the polysaccharides from Hyriopsis cumingii
Klinman et al.	2003	Regulation of CpG‐induced immune activation by suppressive oligodeoxynucleotides
Zayed et al.	2023	Structural tailoring of fucoidan backbones for maximizing their benefits: Enzymatic, chemical, and physical strategies
Yudiati et al.	2021	Alginate oligosaccharide/polysaccharide and lactic acid bacteria (Lactobacillus bulgaricus FNCC–0041 & Streptococcus thermophilus FNCC–0040) as immunostimulants against pathogenic Vibrio spp. using Artemia bio model
Vo et al.	2014	Marine-derived polysaccharides for regulation of allergic responses
CN108409877B (zh)	2020-02-18	浒苔多糖、浒苔寡糖、药物组合物及其用途
Liu et al.	2009	Isolation and identification of two novel SDS‐resistant secreted chitinases from Aeromonas schubertii
Ruiz-Bravo et al.	2001	Biological response modifier activity of an exopolysaccharide from Paenibacillus jamilae CP-7
Eom et al.	2003	Characteristics of chitosanases from Aspergillus fumigatus KB-1
Naser et al.	2015	A new antigen delivery vehicle candidate: Orthochirus iranus scorpion venom entrapped in chitosan nanoparticles
Yamamoto et al.	2000	Oligodeoxyribonucleotides with 5′-ACGT-3′ or 5′-TCGA-3′ sequence induce production of interferons
De Oliva-Neto et al.	2016	Yeasts as potential source for prebiotic β-glucan: Role in human nutrition and health
Kozhemyakina et al.	2010	Conditions of cultivation, composition, and biological activity of mycelium of Flammulina velutipes (Fr.) P. Karst
Henares et al.	2010	Iota-carrageenan hydrolysis by Pseudoalteromonas carrageenovora IFO12985